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Coxiella burnetii endocarditis is the best-described
chronic and life-threatening zoonotic infection [1].
We describe the ﬁrst ﬁve cases of C. burnetii
endocarditis reported in Greece.
Over a 7-year period (2001–2007) the medical
records of ﬁve adult patients with Q fever
endocarditis, hospitalised in three different
healthcare settings in Greece, were retrospectively
reviewed. Diagnosis of Q fever endocarditis was
based on serological (phase I IgG antibody titres
to C. burnetii >1:800) and compatible clinical
criteria [2].
PATIENT 1
A 41-year-old man was admitted with a 3-month
history of fever with rigor, fatigue and malaise.
He had a history of infective endocarditis suc-
cessfully treated 2 years earlier. The patient had a
congenital aortic stenosis, for which he was
operated on 27 years ago, and mitral valve pro-
lapse. Blood cultures were negative. The trans-
thoracic echocardiogram showed a vegetation of
the mitral valve. Serology was positive for C. bur-
netii phase I IgG antibodies (1 ⁄ 30720). He became
apyretic 7 days after the initiation of rifampicin
with doxycycline. The patient is receiving tetra-
cycline as maintenance therapy for a total dura-
tion of 24 months.
PATIENT 2
A 53-year-old man was admitted with a fever of
39C that he had had for about 20 days, accom-
panied by rigors, intense malaise, fatigue, myalgia
and shortness of breath. There was no known
valvulopathy. On examination, splinter haemor-
rhages were present in both hands. A systolic and
diastolic murmur was revealed by aortic valve
examination. Echocardiography showed no veg-
etation. All blood cultures were negative. C. bur-
netii serology was positive for phase I IgG
antibodies (1 ⁄ 1024).
The patient underwent an aortic valve replace-
ment and the PCR performed on the extracted
valve tissue was positive for C. burnetii. He was
treated successfully with tetracycline plus quino-
lone.
PATIENT 3
A 58-year-old patient was admitted 8 months
prior to the diagnosis of C. burnettii endocarditis,
due to pneumonia associated with haemorrhagic
pericardial effusion. Three months later, he
underwent cardiovascular surgery due to pre-
existing aortic valve stenosis. By that time an
aortic valve abscess was revealed and the patient
received vancomycin combined with a third
generation cephalosporin for 42 days. Two days
after the discontinuation of antibiotics the fever
relapsed. All blood cultures were negative. The
echocardiogram showed the formation of a new
abscess on the aortic valve, whereas the serology
and the PCR assay of the blood were positive for
C. burnettii endocarditis (phase I IgG 1 ⁄ 1024). The
regimen was switched to the combination of
tetracycline and quinolone and apyrexia was
obtained.
PATIENT 4
A 35-year-old man was admitted with a 5-month
history of fever of 39–40 C with rigor, in the
evening and night hours. The patient had a
history of aortic valve stenosis. Echocardiography
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showed vegetation on the aortic valve. Repeated
blood cultures remained negative. The patient
received empirically a combination of ampicillin,
vancomycin and gentamicin, and was afebrile
3 days later. Serology was positive for chronic Q
fever (phase I IgG 1 ⁄ 15360). The regimen was
then switched to doxycycline.
PATIENT 5
A 56-year-old man was admitted with a 2-month
history of fever of 38–39C accompanied by
rigors, sweating, intense malaise, weight loss
and myalgia. He had undergone cardiovascular
surgery 2 months before, due to aortic valve
stenosis. On clinical examination the patient had
a changing heart murmur on aortic valve. The
echocardiogram showed no vegetation. All blood
cultures were negative. Serology was positive for
C. burnetii phase I IgG antibodies (1 ⁄ 3200). The
patient received empirically a combination of
quinolone, cephalosporin and vancomycin. After
Q fever diagnosis was conﬁrmed, the patient was
successfully treated with doxycycline and hydro-
chloquine [2–4].
CONCLUSIONS
All patients were male with a median age of 53
(35 –58) years old. Risk factors such as structural
valve disease were present in four patients (80%),
consisting of aortic stenosis in three patients and
of mitral valve prolapse in one patient. The
median duration of illness prior to diagnosis
was 90 (20–240) days. On admission, fever, night
sweating, weight loss and fatigue were observed
in all patients. Echocardiography performed in all
patients showed vegetation in two of them, and a
paravalvular abscess in another patient. Further-
more, all blood cultures were persistently nega-
tive. In all patients speciﬁc antibodies against
Coxiella burnetii had a typical proﬁle for C. burnetii
endocarditis. The median anti-phase I IgG titre
was 1 ⁄ 1600. All patients received speciﬁc antibi-
otic treatment based on tetracycline and all
infections had a favourable outcome. Due to
different institution practices, antibiotic therapy
was not according to the Duke’s criteria in four
out of the ﬁve patients (hydroxychloroquine was
not included in the therapeutic combination);
after a follow-up period of at least 24 months,
no relapses or complications were observed [2–4].
This is the ﬁrst description of ﬁve cases of Q
fever endocarditis in Greece.
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